Biosimilar insulin concepts

被引：1

作者：

Bloomgarden, Zachary T. ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

来源：

JOURNAL OF DIABETES | 2022年 / 14卷 / 04期

关键词：

GLARGINE LANTUS(R); DIABETES PATIENTS; TREATED PATIENTS; CONTROLLED-TRIAL; EFFICACY; TYPE-1; SAFETY; VARIABILITY; LISPRO; ADULTS;

D O I：

10.1111/1753-0407.13267

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：231 / 235

页数：5

共 31 条

[1]

18th Expert Committee on the Selection and Use of Essential Medicines, 2011, REV EV COMP INS HUM

[2]

Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s064, 10.2337/dc10-S011, 10.2337/dc13-S067, 10.2337/dc11-S011, 10.2337/dc12-s011, 10.2337/dc11-S062, 10.2337/dc14-S081, 10.2337/dc10-S062, 10.2337/dc13-S011]

[3] Estimation of global insulin use for type 2 diabetes, 2018-30: a microsimulation analysis [J].

Basu, Sanjay ;

Yudkin, John S. ;

Kehlenbrink, Sylvia ;

Davies, Justine I. ;

Wild, Sarah H. ;

Lipska, Kasia J. ;

Sussman, Jeremy B. ;

Beran, David .

LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (01) :25-33

[4]

Beran D., 2022, DIABETOLOGIA, V11, P1, DOI [10.1007/s00125-022-05680-y, DOI 10.1007/S00125]

[5] Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine (Lantus®) in patients with type 1 diabetes in a randomized controlled trial: the ELEMENT 1 study [J].

Blevins, T. C. ;

Dahl, D. ;

Rosenstock, J. ;

Ilag, L. L. ;

Huster, W. J. ;

Zielonka, J. S. ;

Pollom, R. K. ;

Prince, M. J. .

DIABETES OBESITY & METABOLISM, 2015, 17 (08) :726-733

[6] Efficacy and safety of MYL-1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study [J].

Blevins, Thomas C. ;

Barve, Abhijit ;

Raiter, Yaron ;

Aubonnet, Patrick ;

Athalye, Sandeep ;

Sun, Bin ;

Muniz, Rafael .

DIABETES OBESITY & METABOLISM, 2020, 22 (03) :365-372

[7] Day-to-day variability of insulin requirements in the inpatient setting: Observations during fully closed-loop insulin delivery [J].

Boughton, Charlotte K. ;

Daly, Aideen ;

Thabit, Hood ;

Hartnell, Sara ;

Herzig, David ;

Vogt, Andreas ;

Ruan, Yue ;

Wilinska, Malgorzata E. ;

Evans, Mark L. ;

Coll, Anthony P. ;

Bally, Lia ;

Hovorka, Roman .

DIABETES OBESITY & METABOLISM, 2021, 23 (08) :1978-1982

[8] Efficacy and Safety of Biosimilar SAR342434 Insulin Lispro in Adults with Type 2 Diabetes, Also Using Insulin Glargine: SORELLA 2 Study [J].

Derwahl, Karl-Michael ;

Bailey, Timothy S. ;

Wernicke-Panten, Karin ;

Ping, Lin ;

Pierre, Suzanne .

DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (01) :49-58

[9] AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES [J].

Fonseca, Vivian A. ;

Bloomgarden, Zachary T. ;

Dagogo-Jack, Samuel ;

Grunberger, George ;

Einhorn, Daniel ;

Garber, Alan J. ;

Handelsman, Yehuda ;

Hirsch, Irl B. ;

Umpierrez, Guillermo E. .

ENDOCRINE PRACTICE, 2017, 23 (11) :1345-1349

[10] Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus [J].

Fullerton, Birgit ;

Siebenhofer, Andrea ;

Jeitler, Klaus ;

Horvath, Karl ;

Semlitsch, Thomas ;

Berghold, Andrea ;

Plank, Johannes ;

Pieber, Thomas R. ;

Gerlach, Ferdinand M. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (06)

← 1 2 3 4 →